Ma Wen-Yu, Shen Kai-Sheng, Wang Zhao, Liu Qi, Diao Xin-Jie, Liu Guo-Rong
School of Food and Health, Beijing Technology and Business University, East campus of Beijing Technology and Business University, No.11 of Fucheng Road, Haidian District, Beijing, 100048, China.
Key Laboratory of Geriatric Nutrition and Health, Ministry of Education, Beijing Technology and Business University, Beijing, 100048, China.
Arch Microbiol. 2025 Jul 11;207(9):195. doi: 10.1007/s00203-025-04391-3.
Bacteriocins and essential oils have potential synergistic antimicrobial effects against pathogens, but the poor understanding of their antimicrobial mechanisms, especially against Gram-negative bacteria and fungi, restricts their practical use in public health. Enterocin Gr17 (ENT) is a novel class IIa bacteriocin that exhibits synergistic effects with cinnamaldehyde essential oil (CEO) against some pathogenic Gram-negative bacteria and fungi. This study aimed to further understand the synergistic antimicrobial activity and mechanisms of ENT and CEO against pathogenic Escherichia coli and Candida albicans from the perspectives of cell wall and membrane, morphological structure, respiratory metabolism and gene expression. Results showed that the ENT-CEO combination induced sublethal damage to E. coli and C. albicans, synergistically limiting their growth in a time-dependent manner. For E. coli, ENT and CEO synergistically disrupted the cell wall structure via interfering with membrane potential and targeting cell wall components, then enhanced membrane permeability and formed non-selective pores, leading to K and adenosine triphosphate efflux and severe damage of morphology and intracellular organization. Furthermore, their combination also suppressed the hexose monophosphate respiratory pathway and the expression of growth and virulence-related genes, ultimately accelerating cell death. On the other hand, ENT combined with CEO minimally affected C. albicans morphology but severely disrupted its intracellular organization, indicating mechanistic differences from E. coli. Initially, ENT and CEO synergistically destabilized membrane potential and destroyed C. albicans cell wall homeostasis, facilitating their cellular internalization. They subsequently disrupted cell membrane permeability and integrity, impaired energy metabolism by inhibiting tricarboxylic acid cycle pathway, and down-regulated the growth and virulence-related gene expression, thereby leading to C. albicans cell death. This study provides theoretical support for the industrial application of bacteriocin-essential oil synergistic antimicrobial technology.
细菌素和精油对病原体具有潜在的协同抗菌作用,但对其抗菌机制,尤其是对革兰氏阴性菌和真菌的抗菌机制了解不足,限制了它们在公共卫生领域的实际应用。肠球菌素Gr17(ENT)是一种新型的IIa类细菌素,与肉桂醛精油(CEO)对一些致病性革兰氏阴性菌和真菌具有协同作用。本研究旨在从细胞壁和细胞膜、形态结构、呼吸代谢和基因表达等方面进一步了解ENT和CEO对致病性大肠杆菌和白色念珠菌的协同抗菌活性及机制。结果表明,ENT-CEO组合对大肠杆菌和白色念珠菌造成亚致死损伤,以时间依赖性方式协同限制它们的生长。对于大肠杆菌,ENT和CEO通过干扰膜电位和靶向细胞壁成分协同破坏细胞壁结构,然后增强膜通透性并形成非选择性孔,导致钾离子和三磷酸腺苷外流以及形态和细胞内组织的严重损伤。此外,它们的组合还抑制了磷酸己糖呼吸途径以及生长和毒力相关基因的表达,最终加速细胞死亡。另一方面,ENT与CEO联合使用对白色念珠菌形态影响最小,但严重破坏其细胞内组织,表明与大肠杆菌的作用机制存在差异。最初,ENT和CEO协同破坏膜电位并破坏白色念珠菌细胞壁稳态,促进它们的细胞内化。随后它们破坏细胞膜通透性和完整性,通过抑制三羧酸循环途径损害能量代谢,并下调生长和毒力相关基因表达,从而导致白色念珠菌细胞死亡。本研究为细菌素-精油协同抗菌技术的工业应用提供了理论支持。